Results 161 to 170 of about 292,750 (306)

Targeting lipid scrambling potentiates ferroptosis and triggers tumor immune rejection. [PDF]

Sci Adv
Yang M, Yu Z, Ping J, Duan Y, Tang J, Liu W, He Q, Lai Y, Lam SM, Tang H, Liu Z, Wang W, Zhu M, Hu W, Han Y, Shui G, Hao J, Liu Z, Wu N.   +18 more
europepmc   +1 more source

Building Community Amidst the Institutional Whiteness of Graduate Study: Black Joy and Maroon Moves in an Academic Marronage

Australian Journal of Social Issues, EarlyView.
ABSTRACT This article reflects on the construction of a supportive community of Black Afro‐diasporic graduate students and their supervisors researching issues relating to race in the field of education in Australia. It draws on the concept of marronage—a term rooted in the fugitive act of becoming a maroon, where enslaved people enacted an escape in ...
Hellen Magoi, Casianus Gemoh, Denise Chapman, Edmund Hypolite, Simon Angok, Melanie Baak, Joel Windle   +6 more
wiley   +1 more source

Harnessing Tumor Cell-Derived Exosomes for Immune Rejection Management in Corneal Transplantation. [PDF]

Adv Sci (Weinh)
Yang J, Kang H, Liu Y, Lu S, Wu H, Zhang B, He Y, Zhou W.   +7 more
europepmc   +1 more source

IL1α Antagonizes IL1β and Promotes Adaptive Immune Rejection of Malignant Tumors. [PDF]

Cancer Immunol Res, 2020
Tian T, Lofftus S, Pan Y, Stingley CA, King SL, Zhao J, Pan TY, Lock R, Marglous JW, Liu K, Widlund HR, Fuhlbrigge RC, Cichowski K, Kupper TS.   +13 more
europepmc   +1 more source

Recent advances in animal models for pathological scar research: A comprehensive review of experimental approaches and translational relevance

Animal Models and Experimental Medicine, EarlyView.
Animal models remain indispensable in the study of pathological scars, each offering unique advantages and constraints. Their integration with in vitro and ex vivo systems is key to developing personalized, clinically translatable antifibrotic therapies. Abstract Pathological scarring, manifested in the form of hypertrophic scars (HTS) and keloid scars
Diana‐Larisa Ancuța, Mariana Văduva, Cristin Coman, Iuliana Caraș   +3 more
wiley   +1 more source

A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation

Hepatology, EarlyView., 2022
In this study of the gut mucosal microbiota in primary sclerosing cholangitis (PSC), we found consistent microbiota features associated with PSC and recurrent PSC, PSC with inflammatory bowel disease and a persistent gut dysbiosis after liver transplantation Abstract Background and Aims Several characteristic features of the fecal microbiota have been ...
Mikal Jacob Hole, Kristin Kaasen Jørgensen, Kristian Holm, Peder R. Braadland, Malin Holm Meyer‐Myklestad, Asle Wilhelm Medhus, Dag Henrik Reikvam, Alexandra Götz, Krzysztof Grzyb, Kirsten Muri Boberg, Tom Hemming Karlsen, Martin Kummen, Johannes R. Hov   +12 more
wiley   +1 more source

Immune rejection of human mesenchymal stem cells compared to extracellular vesicles in mice with renal artery stenosis. [PDF]

Stem Cells Transl Med
Arabi TZ, Almasry Y, Xue A, Eirin A, Lerman A, Zhu XY, Lerman LO.   +6 more
europepmc   +1 more source

Engineering Tertiary Lymphoid Structures: Nanomedicine, Bioengineering, and Biomaterials for Precision Immunotherapy

Advanced NanoBiomed Research, EarlyView.
This review explains how biomaterials and nanoparticles can be used to induce or modulate tertiary lymphoid structures (TLSs), which are ectopic immune hubs that form in nonlymphoid tissues during chronic disease and cancer. By comparing different methods, the article highlights design principles for modeling TLSs or recapitulating specific TLS ...
Shaza Karaman, Mei ElGindi, Jeremy Teo
wiley   +1 more source

Genetically Engineered Hypoimmune Human Muscle Progenitor Cells Can Reduce Immune Rejection. [PDF]

Cell Prolif
Chen Y, Wang P, Ma S, Yue C, Liu X, Cheng Y, Liu K, Zhao T, Shyh-Chang N.   +8 more
europepmc   +1 more source

Human ES cell-derived dendritic cells: Meeting the challenge of immune rejection in allogeneic cell therapy. [PDF]

EBioMedicine, 2020
Zenke M.
europepmc   +1 more source